Safety and Efficacy of Intrarenal Arterial Autologous CD34+ Cell Transfusion in Patients With Chronic Kidney Disease: A Randomized, Open-Label, Controlled Phase II Clinical Trial
Stem cells translational medicine - United States
doi 10.1002/sctm.19-0409
Full Text
Open PDFAbstract
Available in full text
Date
April 16, 2020
Authors
Publisher
Wiley